Publications Office of the EU
Poland-Krakow: Various medicinal products - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Poland-Krakow: Various medicinal products

  • Published
    28/11/2015
  • Deadline
    08/01/2016
  • Awarded
    26/01/2016
  • Today
    05/10/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Wojewódzki Specjalistyczny Szpital Dziecięcy im. św. Ludwika w Krakowie
Place of performance
NUTS code: PL213 Miasto Kraków
Location of buyer
NUTS code: Not available
Business sector (Main CPV)
33690000 Various medicinal products
Total estimated contract value (excluding VAT)
178,459.20 PLN
Total final contract value (excluding VAT)
178,548.80 PLN
Number of lots
2
Tender reference number
DZP.272-25/15
Description

3.1. The subject-matter of the contract is the successive delivery of: Tocilizumabum (Pack 1) and vaccines against human papillomavirus (Packet No 2) under 2 packages, hereinafter referred to as ‘the good’, as detailed in Annex 1B to the ToR: Price form.
3.2. The Contractor undertakes to deliver the goods to the Contracting Authority on the basis of orders issued specifying the range and quantity within the shortest possible time, but no longer than 2 days after the order is placed (on Monday to Friday working days).
3.3. The contracting authority will place the order by telephone or fax. The Contractor must confirm the order without delay by fax No + 48 124312898.
3.4. Delivery of the insured goods, together with the loading and unloading of the goods, will be carried out at the contractor’s expense, the place of delivery: The Pharmaceutical Unit at the Contracting Authority’s headquarters.
3.5. The medicines and vaccines covered by the contract must comply with the relevant provisions of the Pharmaceutical Law of 6.9.2001 (consolidated text: Journal of Laws 2008, No 45, item 271 as amended).The medicinal products offered must be authorised under the conditions laid down in the Pharmaceutical Law.
3.6. The quantity indicated in Annex 1B to the ToR may be increased or reduced during the duration of the contract, but not more than 30 % of the quantity set out in the annex under the package in question, in the event of a reduction or increase in the number of patients receiving the goods. This power of the Contracting Authority does not constitute replacement of a contract pursuant to Article 144. 1 of the Public Procurement Act.
3.7. When offering a medicinal product, a foodstuff intended for particular nutritional uses, a medical device on the list of reimbursable medicines, the contractor must take into account the provisions of Article 9 paragraph when calculating the price. 2 of the Act of 12 May 2011 on the reimbursement of medicines, foodstuffs intended for particular nutritional uses and medical devices (Journal of Laws No 2015.345, consolidated text), up to date on which tenders are submitted. In addition, the explanations regarding Article 9 paragraph should be taken into account. 2 of the above-mentioned Acts contained in the Communication from the Minister for Health of 26.3.2012 (letter MZ-PLR-460-12576-160/KB/12). The prices of the medicinal products on Lists B and C of the Notice of the Minister for Health may not be higher than the funding limit.
3.8. Whenever trade marks, patents or origin are used in the description of the contract contained in this ToR, the Contracting Authority shall accept an equivalent solution. An economic operator submitting an equivalent tender, in accordance with the provisions of the PPL, must demonstrate in its tender that the subject-matter of the contract which it offers meets the technical requirements and parameters set out in the tender specifications (including Annex 1B) or provides for solutions with parameters higher than those required by the Contracting Authority – the contractor must attach to its tender documentation confirming this equivalence. In particular, the Contractor is required to ensure that the qualitative and quantitative composition of the active substances meets the requirements of this ToR.
3.9. The contractor must ensure that the qualitative conditions laid down in the production permit or other decisions laid down by the Ministry of Health on the basis of which the goods have been released for free circulation in Poland are met and that the validity periods for the goods delivered are respected.
3.10. The contracting authority reserves the right to ask economic operators during the term of the contract to submit the characteristics of the medicinal products offered and documents authorising the offer for marketing and use in Poland.

Submission Method
Not available
Tenders may be submitted
Submission for one or more lots
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The notice involves a public contract
Conditions for opening tenders (date)
Not available
Place of performance
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.